New cell therapy aims to boost hearing restoration in cochlear implant patients

NCT ID NCT07032038

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests a new cell therapy called Rincell-1 for adults with certain types of hearing loss who are getting a cochlear implant. The study will compare the safety and early effectiveness of receiving the cell therapy plus the implant versus the implant alone. About 20 participants will be followed for a year to see if the therapy is safe and can improve hearing nerve function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SENSORINEURAL HEARING LOSS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

auditory neuropathy Hearing Loss, Sensorineural presbycusis retrocochlear disease sensorineural hearing loss disorder X-linked mixed hearing loss with perilymphatic gusher

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cambridge University Hospital

    Cambridge, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Guy's and St Thomas' Trust

    London, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University Hospitals Birmingham

    Birmingham, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••